Vyome Holdings, Inc. (HIND) Live Share Price, Invest From India

Vyome Holdings, Inc. Stock Performance

as on May 23, 2026 at 2:15 pm IST

Day's Low
Day's High
$2.14
Day's Price Range
$2.25
$2.23
4.04%
Downside
0.90%
Upside
52 Week's Low
52 Week's High
$1.75
52-Week Price Range
$16.00
$2.23
21.52%
Downside
617.49%
Upside

Vyome Holdings, Inc. share price movements today

Previous Close: $2.23
Open: $2.14
Volume: 229.4K
Day's Low - High: $2.14 - $2.25
52 Week Low - High: $1.75 - $16.00

Vyome Holdings, Inc. Historical Returns

1 Month Return: + 0.9 %
3 Month Return: -28.98 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Vyome Holdings, Inc. Stock Fundamentals & Key Indicators

Check Vyome Holdings, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$14.8M

EPS (TTM)

-0.81

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-665.57%

Vyome Holdings, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vyome Holdings, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Vyome Holdings, Inc.	NA	$14.8M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.9B	117.32%	75.18	12.55%
Vertex Pharmaceuticals Inc	BUY	$109.2B	105.26%	25.58	35.51%
Regeneron Pharmaceuticals Inc	BUY	$68.1B	28.4%	15.87	29.65%

Indian Investors' Interest in Vyome Holdings, Inc. Stock

Search interest for Vyome Holdings, Inc. Stock has increased by 53% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 24, 2026 to May 24, 2026

Change:53% versus previous 30 day period

Vyome Holdings, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	2	1	1	2	0	1	1	0	0	0
Gross Profit	1	1	1	1	0	0	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-3	-2	-1	-1	0	1	-2	-8	-1	0
Net Profit Margin	-163.99%	-112.81%	-81.17%	-68.98%	-499.05%	132.43%	-211.76%	-24356.17%	-3352.75%	-3048.05%

Vyome Holdings, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	1	0	15	11	13	11	8	8	0
Gross Profit	0	0	0	9	6	8	6	5	5	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-23	-33	-81	-74	-21	-63	-46	-11	-7	-10
Net Profit Margin	-2969.62%	-2627.34%	-13375.68%	-491.80%	-191.43%	-464.31%	-411.16%	-131.22%	-89.06%	-3209.75%

Insights on Vyome Holdings, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -8.43M → -962.91K (in $), with an average increase of 307.7% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, HIND stock has moved up by 18.0%
NO EFFECT
Against Peers
In the last 3 years, Vyome Holdings, Inc. Common Stock has experienced a drawdown of -99.9%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 87.0%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 9.2% return, outperforming this stock by 62.4%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 36.55K → 31.59K (in $), with an average decrease of 13.6% per quarter

About Vyome Holdings, Inc.

Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company's lead product candidate VT-1953, a dual DNA Gyrase/Topoisomerase inhibitor and immunomodulator in a topical gel formulation that is in phase 2 clinical stage for the treatment of bacterial conjunctivitis. It also develops VT-1908, a topical eye drop is an inosine 5'-monophosphate dehydrogenase enzyme inhibitor to treat immunoinflammatory conditions of the eye; and VB-1953, which is in phase 2 clinical stage for the treatment of inflammatory acne. In addition, the company develops antifungal products using the molecular replacement therapy (MRT) platform. It has a collaboration and license agreement with Sun Pharma Laboratories Limited to develop and commercialize next-generation antifungal products. The company is based in Cambridge, Massachusetts.

Organisation	Vyome Holdings, Inc.
Headquarters	Harvard Square, Cambridge, MA, United States, 02138
Industry	Biotechnology
CEO	Mr. Venkateswarlu Nelabhotla M.B.A.
E-voting on shares	Click here to vote

Key Management of Vyome Holdings, Inc.

Name	Title
Dr. Charles G. Chavdarian Ph.D.	Senior Vice President of Product Development & Regulatory CMC
Dr. Tamara Agajanov M.D.	Senior Vice President of Clinical Development
Mr. Venkateswarlu Nelabhotla M.B.A.	Co-Founder, CEO, President & Director
Dr. Shiladitya Sengupta M.Sc., Ph.D.	Co-Founder, Director and Member of Scientific & Clinical Advisory Board
Mr. Robert Dickey IV	Chief Financial Officer
Dr. Richard Fahrner Ph.D.	Chief Technology Officer

FAQs

What is Vyome Holdings, Inc. share price today?

Vyome Holdings, Inc. share price today is $2.23 as on May 23, 2026 at 8:45 am IST at the close of the market. Vyome Holdings, Inc. share today touched a day high of $2.25 and a low of $2.14.

What is the 52 week high and 52 week low for Vyome Holdings, Inc. share?

Vyome Holdings, Inc. share touched a 52 week high of $16 on January 1, 1970 and a 52 week low of $1.75 on January 1, 1970. Vyome Holdings, Inc. stock price today i.e. May 23, 2026 at 8:45 am IST is closed at $2.23,which is 86.06% down from its 52 week high and 27.43% up from its 52 week low.

What is Vyome Holdings, Inc.'s market capitalisation today?

Vyome Holdings, Inc. market capitalisation is $0.00T as on May 23, 2026 at 8:45 am IST.

How to invest in Vyome Holdings, Inc. Stock (HIND) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Vyome Holdings, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vyome Holdings, Inc. Shares that will get you 0.6726 shares as per Vyome Holdings, Inc. share price of $2.23 per share as on May 23, 2026 at 8:45 am IST.

What is the minimum amount required to buy Vyome Holdings, Inc. Stock (HIND) from India?

Indian investors can start investing in Vyome Holdings, Inc. (HIND) shares with as little as ₹95.68 or $1 (as of May 24, 2026 at 7:50 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.80 in Vyome Holdings, Inc. stock (as per the Rupee-Dollar exchange rate as on May 24, 2026 at 7:50 pm IST). Based on Vyome Holdings, Inc. share’s latest price of $2.23 as on May 23, 2026 at 8:45 am IST, you will get 4.4843 shares of Vyome Holdings, Inc.. Learn more about fractional shares .